【Nipro】2026 Financial Results | Net Sales of JPY 660.5 billion, Net Income of JPY 13.5 billion increased

Performance Overview

Nipro achieved net sales of JPY 660.5 billion (YoY +2.5%) in the fiscal year ending March 2026, with operating income of JPY 37.6 billion (+41.5%) and net income of JPY 13.5 billion (+164.1%), reflecting significant profit growth. Expansion in overseas markets and successful healthcare-related businesses contributed to balancing profitability and growth. Segments such as healthcare and pharmaceutical-related businesses performed steadily, especially contributing to the increase in net income attributable to owners of the parent. The company aims for sustainable growth by expanding high-value-added products and improving production efficiency.

Future Outlook and Impact on Shareholders

For the fiscal year ending March 2027, net sales are expected to reach JPY 700.0 billion (+6.0%), and net income to JPY 15.0 billion (+11.1%), continuing the trend of revenue and profit growth. The company plans to further enhance profitability through expanding high-value-added products and reducing production costs. Dividend projections have also been increased, reflecting a focus on shareholder returns. The company emphasizes stable supply amidst geopolitical risks and logistics challenges, demonstrating a long-term strategy aimed at increasing corporate value.